GoodRx Care Appears in 76.2% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.

Answer Capsule

In November 2026, GoodRx Care appeared in 214 of 281 AI answers included in the ED Treatment Pills benchmark (76.16%). It received 168 recommendations (59.79%), with 122 Top 3 placements and 62 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.

Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. The historical results show how the figures changed across available months. Different monthly samples limit those comparisons, and conflicting AI claims require verification before corrections are proposed.

Current AI visibility

Questions This Section Answers

• How do GoodRx Care mentions, recommendations and placements compare with its ED Treatment Pills peers?

GoodRx Care recorded 214 mentions (76.16%) and 168 recommendations (59.79%) across 281 answers included in the benchmark. Top 3 placements numbered 122; first-place recommendations numbered 62. Framing among its mentions was 171 positive, 43 neutral and 0 negative.

GoodRx Care sits third in the benchmark, behind two larger rivals on every headline measure. Its mentions and recommendations are strong in absolute terms, so the gap is one of degree rather than absence. The practical question is where a modest lift in placement would matter most, not whether the brand is visible at all.

Framing is overwhelmingly positive, with no negative mentions recorded. That is a useful asset: the answers that do discuss GoodRx Care tend to do so favourably. The agency would treat this as a base to protect while working on the weaker placement measures, rather than a problem to fix.

The distance between recommendations and first-place finishes is the clearest opening. GoodRx Care is endorsed often but named first far less often than the leader. Proposed work would examine which question types produce first-place answers and build briefs aimed at those, while keeping expectations tied to measured outcomes rather than promised gains.

What changed since last month

Questions This Section Answers

• How did GoodRx Care counts and coverage differ across the available monthly snapshots?

Only months with verified results are shown. Monthly sample coverage is listed in Methodology.

From October 2026 to November 2026, GoodRx Care's mention count rose from 207 to 214, while its recommendation count rose from 151 to 168. The recommendation rate was 51.01% and 59.79% respectively.

Between the two recorded months, mentions, recommendations and both placement measures all moved upward. The recommendation rate rose alongside the counts. These are separate selected samples, so the movement describes what was recorded in each month rather than a trend the agency can attribute to any cause.

The answer samples also differed in size between months, which limits direct comparison of rates. The agency would present the November position as the current baseline and treat October as context, not as proof of direction. Any future comparison should be read the same way until several months share consistent coverage.

For planning, the useful signal is that GoodRx Care enters the next period with more endorsements and more first-place finishes on record than the prior month. Proposed work would aim to hold and extend that position, with results reported separately from the work delivered.

Step 1. Measure

Questions This Section Answers

• What should the agency measure and verify first for GoodRx Care?

AI answers contained 1 conflicting claim about GoodRx Care: 0 critical, 0 high, 1 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

A single conflicting claim about GoodRx Care was recorded, rated medium priority. That is a manageable fact-checking load rather than a crisis. The rating orders the work; it does not establish that the company or any publisher got something wrong.

The proposed first step is a visibility scorecard that pairs the benchmark position with a short list of claims worth checking. Each claim would carry an owner, the evidence needed to settle it, and a review status. This gives the client a clear queue instead of a vague concern about accuracy.

Separating measurement from correction matters here. The scorecard records what answers say; the fact-review list records what still needs checking against primary sources. The agency would keep those two records distinct so that neither is mistaken for a finding of error.

Step 2. Make the website consistent

Questions This Section Answers

• Which recorded claim differences about GoodRx Care should be verified before proposed page edits?

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

The disputed topic concerns the stated visit price without insurance, where recorded answers give different figures. Both versions are quotations from AI answers, not verified company facts. Different dates or plan contexts could account for an apparent conflict, so the entity, date and source need resolving before anyone decides a correction is warranted.

The proposed work is a fact check against current primary sources, followed by a conditional page brief only if the company's own materials confirm the accurate figure. If they do not, the item closes as a no-change decision. The agency would not rewrite a page on the strength of an AI claim alone.

Keeping this conditional protects the client from acting on unverified information. It also means the brief, if it proceeds, rests on approved facts the company can stand behind.

Step 3. Align the external narrative

Questions This Section Answers

• Which cited third-party pages are relevant to fact review for GoodRx Care?

These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.

Several cited pages were selected for review because they relate to GoodRx Care in the captured answers. Citation counts vary widely across them, and a page linked to a conflicting claim is not necessarily its cause. The same answer can also touch more than one page, so the rows are not a clean ranking of influence.

The proposed work is a source review: check what each page currently says, confirm whether it addresses the disputed topic, and decide whether an evidence-backed request is justified. Requests would be framed around verified facts and made without assuming publisher control or error.

Where a page turns out to be accurate or unrelated, it drops from the queue. The agency would report confirmed edits, no-change decisions and outstanding requests separately so the client can see what was actually done.

Step 4. Optimize priority company pages

Questions This Section Answers

• Which observed GoodRx Care website pages should receive review briefs?

The company's website was cited 511 times across 96 distinct page addresses; the table shows 8 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.

The company's own pages are cited heavily, and the selected list concentrates on erectile-dysfunction treatment and telehealth content. That makes these pages the natural focus for briefs. One listed page recorded no matching answers, which simply means no citation was captured there, not that the page is weak.

Proposed page briefs would use approved company facts and the buyer questions observed in the research. Each brief would state the audience question the page should answer, the facts it may use, and the reviewer who signs off. Existing coverage would be checked before any new page is proposed.

A cited page is not automatically a page that accompanied a recommendation, so the briefs would target clarity and factual accuracy rather than chasing citation counts directly.

Step 5. Publish around buyer questions

Questions This Section Answers

• Which observed buyer questions support content briefs for GoodRx Care?

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

The observed questions cluster around choosing an online ED treatment, an online prescription service and an online doctor. GoodRx Care appears in most of these answers and is recommended in nearly all of them, which suggests the brand already fits the way buyers frame the choice.

The proposed work is buyer-question content: briefs that answer these questions directly, using approved facts and a clear comparison of options. Existing pages would be checked first, since some questions may already be covered and need refinement rather than a new page.

These are recorded answer observations, not search volume or proof of missing content. The agency would treat them as prompts for briefs and let the client's own evidence decide what gets published.

Our 90-day action plan

Questions This Section Answers

• How should the agency sequence the proposed GoodRx Care work and judge completion?

The first month produces a baseline scorecard, a scoped fact-review register and a shortlist of pages and sources. Each record gets an owner, an evidence requirement and a review status, so the client can see what is open and what is settled.

The second month turns approved findings into page briefs and justified publisher requests. Confirmed edits, no-change decisions, requests and responses are logged separately, which keeps a request distinct from an outcome.

The third month adds buyer-content briefs and a fresh scorecard. Completed work is reported apart from measured answer outcomes, with the comparability limits stated alongside. Nothing in the plan promises a visibility gain; it promises a clear record of what was done and what the next measurement shows.

Methodology

Questions This Section Answers

• How are GoodRx Care answer metrics and citation populations defined?

This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 281 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.

An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.

The wider citation analysis covers 800 captured answers and 5650 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.

Monthly sample coverage:

July 2026 measured a different set of companies, so it is excluded from this comparison. August 2026 measured a different set of companies, so it is excluded from this comparison. September 2026 measured a different set of companies, so it is excluded from this comparison.

The answer samples differ between months. These comparisons show how the recorded results changed; they do not establish why they changed.

The benchmark covers answers that met inclusion rules, and a company counts as recommended only when an answer endorses it with positive wording. Placement counts sit inside recommendations rather than adding to them. Because one answer can discuss several companies, company totals cannot be summed into a count of answers.

The collection dates for the original answers are unverified, and cited pages still need independent checking. Monthly samples differ, so comparisons show what was recorded, not why it changed. Sentiment describes answer wording, not customer satisfaction.

Our first three priorities

First, settle the visit-price conflict through primary-source verification before any page work begins. The claim is rated medium, so it belongs in the queue but should not displace broader measurement. A confirmed fact or a no-change decision both close the item cleanly.

Second, build page briefs around the erectile-dysfunction and telehealth pages that answers cite most, using approved facts and the buyer questions already observed. Existing coverage gets checked first so effort goes where it is needed.

Third, review the selected external pages and prepare evidence-backed requests only where current contents justify them. Throughout, the agency would report delivered work separately from measured visibility, so the client can judge progress on evidence rather than expectation.